Prosecution Insights
Last updated: November 04, 2026
Application No. 18/968,182

SYSTEM AND METHOD OF USE FOR HALOTHERAPY SESSIONS

Non-Final OA §DOUBLEPATENT
Filed
Dec 04, 2024
Priority
Apr 24, 2019 — provisional 62/837,751 +3 more
Examiner
ZIEGLER, MATTHEW D
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Halotherapy Center LLC
OA Round
1 (Non-Final)
48%
Grant Probability
Moderate
1-2
OA Rounds
1y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
113 granted / 237 resolved
-22.3% vs TC avg
Strong +53% interview lift
Without
With
+53.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
28 currently pending
Career history
289
Total Applications
across all art units

Statute-Specific Performance

§101
3.5%
-36.5% vs TC avg
§103
50.2%
+10.2% vs TC avg
§102
16.7%
-23.3% vs TC avg
§112
25.1%
-14.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 237 resolved cases

Office Action

§DOUBLEPATENT
DETAILED ACTION This Office Action is in response to the filing of the application on 12/04/2024. Since the initial filing, no claims have been amended, added, or cancelled. Thus, claims 1-20 are pending in the application. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-3, 5-7, 9, 11, 15-17, and 19 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 3, and 11 of U.S. Patent No. 11,819,515 in view of Everest (DE 102008016232; see attached translated copy). The claims of the instant application amount to no more than slight variations or a change in wording in relation to the claims of the ‘515 patent, and thus are not patentably distinct. As detailed below, each claim of the instant application is either 1) effectively identical with regards to the recited limitations of the ‘515 patent, despite any slight change in wording, or 2) an obvious change or variation to the claims of the ‘515 patent that would be obvious to one of ordinary skill in the art. Instant Application ‘515 Patent A halotherapy enclosure, comprising: a plurality of walls delimiting an enclosed space sufficiently sized for receiving a removable physical exertion element; at least one salt aerosol discharge system that includes a blower configured to disperse salt particles into the enclosed space; at least one red light device disposed within the enclosed space, the red light device configured to emit a plurality of red light waves for therapeutic benefit; and at least one controller configured to control the dispersion of salt particles into the enclosed space. A halotherapy and red light system, comprising: an enclosed space including a plurality of upstanding side walls delimiting a space that is sufficient sized for at least one physical exertion machine and configured to allow a person to exercise using the physical exertion machine in an at least a vertical or horizontal orientation; a machine having a body comprising of a back portion and a front portion, a grinding mechanism that includes a grinder and a discharge mechanism, disposed about the front portion of the machine is a control panel and at least two vents in communication with an exhaust of the discharge mechanism that disperse salt particles into air contained inside of the enclosed space; at least one physical exertion machine disposed inside of the enclosed space; and a plurality of red light devices disposed about a ceiling of the enclosed space, each one of the red light devices configured to emit red light waves for therapeutic benefit. As seen in the above table, claim 1 of the instant application and claim 1 of the ‘515 patent share many similarities in claim scope and language. The ‘515 patent directs to a “red light system” in the preamble, which is understood to be part of both the claims, and amounts to nothing more than a change in terminology for the same type of device. The “blower” of the instant application has the same function as the “discharge mechanism” of the ‘515 patent, and is understood to merely be a narrower interpretation of a broader category, resulting in the same system. The only difference was substance between the two is that the instant application recites a controller that communicates with the salt dispersion device, whereas the ‘515 patent merely mentions the salt dispersion device having a control panel. However, while the ‘515 patent does not disclose the same controller configuration as the instant application, it is known in the art to use a single control device to simultaneously control different subsystems, as taught by Everest. Everest discloses a similar system for having an enclosed room that is entrained with salt in the air and has therapeutic lights placed around the room (the “Klimatron” of Fig. 1, which produces a salt-entrained air (see [0013] and [0023]) in conjunction with a light therapy (see [0013] and [0021])), where a control unit is used to control both the salt production and the lights (see [0039] and [0041] where the system that creates the salted air and the lights are both controlled by the control unit). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the control panel of the ‘515 patent to be a controller for operatively controlling both the salt dispersion device and the lights as taught by Everest, as it would provide a simplified control system that utilizes only a single controller, with the benefit of being able to more easily coordinate changes in the salt production and lights to act cooperatively more better therapeutic benefit. Additionally, it is understood that a person of ordinary skill in the art would recognize that centralizing a control system to be only a single controller helps simplify the design, makes it easier to control the subsets of the system to be in tune with one another, and amounts to nothing more than an obvious modification of a control system. For these reasons, the instant application is understood to not be patentably distinct from the modified ‘515 patent. Claim 2 of the instant application corresponds to claim 3 of the modified ‘515 patent. Claim 3 of the instant application corresponds to claim 1 of the modified ‘515 patent, where it is understood that having the salt aerosol discharge system be standalone is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 5 of the instant application corresponds to claim 1 of the modified ‘515 patent. Claim 6 of the instant application corresponds to claim 1 of the modified ‘515 patent. Claim 7 of the instant application corresponds to claim 11 of the modified ‘515 patent, where it is understood that the system of the ‘515 patent includes the sensors. Further, the addition of a salinity sensor is understood to be an obvious matter of design choice, and would merely offer additional readings regarding a well-known and desired measurement. Claim 9 of the instant application corresponds to claim 1 of the modified ‘515 patent, for the same reasons as claim 1 above (and modified in identical fashion in light of Everest). The differences between claim 1 and claim 9 of the instant application are minor, and to not amount to a patentable distinction. Claim 11 of the instant application corresponds to claim 1 of the modified ‘515 patent, where it is understood that having the salt aerosol discharge system be removable is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 15 of the instant application corresponds to claim 1 of the ‘515 patent, as further modified by Everest. For the same reasons as claims 1 and 9 above, claim 15 is a method claim that merely provides a device that is effectively identical to claim 1 of the ‘515 patent (having the same differences in recited structure as claim 1 above, and equally as obvious in light of Everest). The following steps are merely using the physical exertion device for its intended purpose. As such, claim 15 of the instant application is not patentably distinct from a modified claim 1 of the modified ‘515 patent. Claim 16 of the instant application corresponds to claim 3 of the modified ‘515 patent. Claim 17 of the instant application corresponds to claim 1 of the modified ‘515 patent, where it is understood that having the salt aerosol discharge system be removable is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 19 of the instant application corresponds to claim 1 of the modified ‘515 patent. Claims 4, 12, 13, 18, and 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 9 and 15, respectively, of U.S. Patent No. 11,819,515 in view of Everest as seen above, and further in view of Shurtleff (US Pat. 9,629,777). Claim 4 of the instant application corresponds to claim 1 of the modified ‘515 patent, except where it lacks a detailed description of the red light device on the upstanding sidewalls. However, Shurtleff teaches a similar system with a room having an exercise apparatus in conjunction with applied red lights, where the lights are applied to the sidewalls of the room (infrared lights 100 in Figs. 15-16). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the location of the red lights of the modified ‘515 patent to be on the sidewalls as taught by Shurtleff, as it would provide additional locations and angles for the lights, to ensure better light coverage and intensity for a more thorough and consistent therapeutic effect. Further, it would be a simple matter of design choice for one of ordinary skill in the art to change the location of the red lights in the room, as it would still result in red light being applied to the room and the user within. Claim 12 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where it lacks a detailed description of the red light device on the sidewalls. However, Shurtleff teaches a similar system with a room having an exercise apparatus in conjunction with applied red lights, where the lights are applied to the sidewalls of the room (infrared lights 100 in Figs. 15-16). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the location of the red lights of the modified ‘515 patent to be on the sidewalls as taught by Shurtleff, as it would provide additional locations and angles for the lights, to ensure better light coverage and intensity for a more thorough and consistent therapeutic effect. Further, it would be a simple matter of design choice for one of ordinary skill in the art to change the location of the red lights in the room, as it would still result in red light being applied to the room and the user within. Claim 13 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where it lacks a detailed description of the red light device on one or more of the walls. However, Shurtleff teaches a similar system with a room having an exercise apparatus in conjunction with applied red lights, where the lights are applied to the sidewalls of the room (infrared lights 100 in Figs. 15-16). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the location of the red lights of the modified ‘515 patent to be on the sidewalls as taught by Shurtleff, as it would provide additional locations and angles for the lights, to ensure better light coverage and intensity for a more thorough and consistent therapeutic effect. Further, it would be a simple matter of design choice for one of ordinary skill in the art to change the location of the red lights in the room, as it would still result in red light being applied to the room and the user within. Claim 18 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where it lacks a detailed description of the red light device on the upstanding sidewalls. However, Shurtleff teaches a similar system with a room having an exercise apparatus in conjunction with applied red lights, where the lights are applied to the sidewalls of the room (infrared lights 100 in Figs. 15-16). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the location of the red lights of the modified ‘515 patent to be on the sidewalls as taught by Shurtleff, as it would provide additional locations and angles for the lights, to ensure better light coverage and intensity for a more thorough and consistent therapeutic effect. Further, it would be a simple matter of design choice for one of ordinary skill in the art to change the location of the red lights in the room, as it would still result in red light being applied to the room and the user within. Claim 20 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where it lacks a detailed description of the red light device on the upstanding sidewalls. However, Shurtleff teaches a similar system with a room having an exercise apparatus in conjunction with applied red lights, where the lights are applied to the sidewalls of the room (infrared lights 100 in Figs. 15-16). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention to modify the location of the red lights of the modified ‘515 patent to be on the sidewalls as taught by Shurtleff, as it would provide additional locations and angles for the lights, to ensure better light coverage and intensity for a more thorough and consistent therapeutic effect. Further, it would be a simple matter of design choice for one of ordinary skill in the art to change the location of the red lights in the room, as it would still result in red light being applied to the room and the user within. Claims 8 and 14 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 9, respectively, of U.S. Patent No. 11,819,515 in view of Everest as seen above, and further in view of Budarin (WO 2008/092465; see attached translated copy). Claim 8 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where there is no detailed description that the enclosure is transportable. However, Budarin teaches a similar halotherapy room device, which is a pod that can be moved and transported around as needed (see Fig. 6). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the enclosure of the modified ‘515 patent to be a pod that can be moved as taught by Budarin, as it would allow for the system to be taken to other locations and used accordingly, improving the functionality of the device and allowing for different use cases (such as home use or mobile clinics). Claim 14 of the instant application corresponds to claim 1 of the modified ‘515 patent, excepting where there is no detailed description that the enclosure is transportable. However, Budarin teaches a similar halotherapy room device, which is a pod that can be moved and transported around as needed (see Fig. 6). Therefore it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the enclosure of the modified ‘515 patent to be a pod that can be moved as taught by Budarin, as it would allow for the system to be taken to other locations and used accordingly, improving the functionality of the device and allowing for different use cases (such as home use or mobile clinics). Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1, 4, 6-7, 14, and 17 of U.S. Patent No. 12,186,339. Claim 1 of the instant application corresponds to claim 1 of the ‘339 patent. Claim 2 of the instant application corresponds to claim 1 of the ‘339 patent, where the placement of the salt aerosol discharge system in the enclosed space is a matter of design choice, and a person could choose to have it attached to a wall, in order to be out of the way and not block the central area of the space. Claim 3 of the instant application corresponds to claim 1 of the ‘339 patent, where it is understood that having the salt aerosol discharge system be removable is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 4 of the instant application corresponds to claim 4 of the ‘339 patent. Claim 5 of the instant application corresponds to claim 4 of the ‘339 patent, where it would be an obvious matter of design choice to choose the ceiling as one of the possible walls that a red light can be attached to. Claim 6 of the instant application corresponds to claim 6 of the ‘339 patent. Claim 7 of the instant application corresponds to claim 7 of the ‘339 patent. Claim 8 of the instant application corresponds to claim 14 of the ‘339 patent, where it is understood that claims 1 and 9 are equally as applicable to the instant application. Claim 9 of the instant application corresponds to claim 1 of the ‘339 patent. Claim 10 of the instant application corresponds to claim 1 of the ‘339 patent, where the placement of the salt aerosol discharge system in the enclosed space is a matter of design choice, and a person could choose to have it attached to a wall, in order to be out of the way and not block the central area of the space. Claim 11 of the instant application corresponds to claim 1 of the ‘339 patent, where it is understood that having the salt aerosol discharge system be removable is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 12 of the instant application corresponds to claim 4 of the ‘339 patent. Claim 13 of the instant application corresponds to claim 17 of the ‘339 patent, where it is understood that claims 1 and 16 are equally as applicable to the instant application. Claim 14 of the instant application corresponds to claim 14 of the ‘339 patent. Claim 15 of the instant application corresponds to claim 1 of the ‘515 patent. For the same reasons as claims 1 and 9 above, claim 15 is a method claim that merely provides a device that is effectively identical to claim 1 of the ‘515 patent. The following steps are merely using the physical exertion device for its intended purpose. As such, claim 15 of the instant application is not patentably distinct from claim 1 of the modified ‘515 patent. Claim 16 of the instant application corresponds to claim 1 of the ‘339 patent, where the placement of the salt aerosol discharge system in the enclosed space is a matter of design choice, and a person could choose to have it attached to a wall, in order to be out of the way and not block the central area of the space. Claim 17 of the instant application corresponds to claim 1 of the ‘339 patent, where it is understood that having the salt aerosol discharge system be removable is an obvious modification of making the components of the system separable, and thus is not a patentable difference. Claim 18 of the instant application corresponds to claim 4 of the ‘339 patent. Claim 19 of the instant application corresponds to claim 4 of the ‘339 patent, where it would be an obvious matter of design choice to choose the ceiling as one of the possible walls that a red light can be attached to. Claim 20 of the instant application corresponds to claim 14 of the ‘339 patent. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATTHEW D ZIEGLER whose telephone number is (571)272-3349. The examiner can normally be reached Mon-Fri 10:00-6:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Timothy Stanis can be reached at (571)272-5139. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MATTHEW D ZIEGLER/Examiner, Art Unit 3785 /TIMOTHY A STANIS/Supervisory Patent Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Dec 04, 2024
Application Filed
Oct 21, 2026
Non-Final Rejection mailed — §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12751534
BEAUTY DEVICE
4y 4m to grant Granted Oct 06, 2026
Patent 12697269
ORTHOPEDIC STANDING AND WALKING AID
6y 11m to grant Granted Aug 04, 2026
Patent 12673173
MEDICAMENT DELIVERY DEVICE
4y 8m to grant Granted Jul 07, 2026
Patent 12661478
Regenerable Carbon Dioxide Scrubber
5y 3m to grant Granted Jun 23, 2026
Patent 12653977
ASSEMBLIES AND METHODS FOR DETECTING ACCIDENTAL EXTUBATION OF A TUBE
5y 3m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
48%
Grant Probability
99%
With Interview (+53.2%)
3y 5m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 237 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month